All Videos

Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.

Experts in atopic disease management review the efficacy and safety data of the JAK inhibitor class, highlighting the importance of time to treatment response and itch reduction.

Drs Alexandra Golant and Brett King discuss the role that atopic disease severity and treatment resistance play in the selection of oral vs systemic treatment for their patients.

Brett King, M.D, Ph.D and Alexandra Golant M.D comment on their considerations on the management of patients suffering from atopic dermatitis, highlighting the importance of body surface area and patient preference in treatment selection.

Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, discuss the relevance of the 4-year efficacy data for dupilumab in adults with moderate to severe atopic dermatitis, with a focus on IGA and EASI scores.

Continuing their discussion about safety, Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, take a closer look at conjunctivitis data from the long-term use of dupilumab

In this week’s Pointers with Dr Portela, the 208SkinDoc interviews the founder of dermstore.com.

Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, review the design of the LIBERTY-AD open-label extension trial and share clinical context regarding safety findings.

Thought leaders share strategies for talking to patients about the importance of treatment adherence in the long-term management of atopic dermatitis.

Experts describe roflumilast patient selection for plaque psoriasis treatment.

Linda Stein Gold, MD, and Jennifer Soung, MD, discuss real world experience of using roflumilast for plaque psoriasis therapy.

Dr Joshua Zeichner reviews the mechanism of action of Isotretinoin and highlights utilization requirements in patients prescribed this treatment.

Joshua Zeichner, MD, shares his insight into some causes of acne and the utility of clascoterone cream 1% combat this condition.

An expert in acne management provide his opinion on the differences between generic vs brand acne treatments and shares his thoughts on the utilization of available isotretinoin formulations.

Aaron Farberg, M.D discusses some common acne causes, highlighting the role of stress, diet, and androgen receptors for this condition.

Dr Aaron Farberg shares his recommendations for discussing acne treatment options with patients and provides insight on setting and managing patients’ goals and expectations.

Jennifer Soung, MD, review long term data for tapinarof for the treatment of plaque psoriasis.

Experts in plaque psoriasis provide an overview of the itch response and tolerability profile of tapinarof.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses if telehealth is here to stay in dermatology.

Linda Stein Gold, MD, reviews phase III data for the topical agent tapinarof for the treatment of plaque psoriasis.

Linda Stein Gold, MD, and Jennifer Soung, MD, provides an overview of the safety profile and topical vehicle of roflumilast for the treatment of plaque psoriasis.

Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, evaluate the effect of the rapidly changing therapeutic landscape in atopic dermatitis.

Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, review the burden of atopic dermatitis and discuss how they talk to patients about the impact their disease has on their lives.

Linda Stein Gold, MD, discusses the itch response of roflumilast for the treatment for plaque psoriasis.

Experts in plaque psoriasis discuss the primary endpoint data responses of roflumilast in the DERMIS-1/DERMIS-2 trials.

Dr Leon Kircik, comments on the impact the multiple formulations of isotretinoin had on acne care; and highlights the efficacy differences between generic vs brand formulations.

Leon Kircik, M.D., discusses the indication of isotretinoin for use in patients suffering from acne, highlighting the difference between high and low dose administration needs.

An expert in acne management shares her insight into the patient characteristics a provider needs to consider when assessing the risk/benefit of a therapeutic agent for the management of acne.

Dr Zoe Diana Draelos discusses the role of ancillary skin care products in the management of acne and stresses the importance of setting patient expectations.

Zoe Diana Draelos, MD comments on the importance of tailoring acne treatments based on disease severity and the ability to target key acne pathogenesis factors.